Somavert

Active Ingredient(s): Pegvisomant
FDA Approved: * March 25, 2003
Pharm Company: * PHARMACIA AND UPJOHN
Category: Acromegaly

Pegvisomant (trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.[1] It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy.[2] It is delivered as a powder that is mixed with water and injected under the skin.[3] Contents 1 Discovery 2 Struct... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Somavert Kit
NDC: 0009-5176
Labeler:
Pharmacia and Upjohn Company
Somavert Kit
NDC: 0009-5178
Labeler:
Pharmacia and Upjohn Company
Somavert Kit
NDC: 0009-5180
Labeler:
Pharmacia and Upjohn Company
Somavert Kit
NDC: 0009-5199
Labeler:
Pharmacia and Upjohn Company
Somavert Kit
NDC: 0009-5200
Labeler:
Pharmacia and Upjohn Company
Somavert Kit
NDC: 0009-7166
Labeler:
Pharmacia and Upjohn Company LLC
Somavert Kit
NDC: 0009-7168
Labeler:
Pharmacia and Upjohn Company LLC
Somavert Kit
NDC: 0009-7188
Labeler:
Pharmacia and Upjohn Company LLC
Somavert Kit
NDC: 0009-7199
Labeler:
Pharmacia and Upjohn Company LLC
Somavert Kit
NDC: 0009-7200
Labeler:
Pharmacia and Upjohn Company LLC